Introduction
Export Market
Export Lines
The main objective of Elea Laboratories is to increase its participation in the local market and its presence in Latin America and the rest of the world.
Due to the fact that we have a strong portfolio of our own and in-licensed products from leading international companies, in addition to a strong R& D Department and the input from local and international academic centers providing world class projects, we are in a position to offer, license-out, a wide variety of pharmaceutical products, covering diverse therapeutic groups.
Our priority is also focused on cooperating with multinational companies by means of Co-marketing, Licensing-in and representations. We can offer the backing and experience of specific business units of leading brands, as well as leadership positions in the different business segments we participate in. In addition, we have a strong sales and distribution network, one of the strongest in the Argentine pharmaceutical market.
If you are interested in developing a business relationship with our company, click here.
|
Elea is dedicated to pursuing the opportunities of new markets for our existing products and novel developments.
Our strong alliances, our sensitivity to local markets, and our flexibility in working with other companies can create new and lucrative opportunities for us and for our partners.
Elea offers a portfolio of drugs to cover various therapeutic areas such as Cardiovascular, Central Nervous System, Anti-Infectives, Biosimilars and Women Health Care.
Elea has established its presence on the International market with products currently available in South America, Central America, the Middle East, the Ex-Soviet Union, Africa and others. Our company has achieved this success through supply agreements with other Pharmaceutical companies or through Local Pharmaceutical Distributors who market our products both under Elea´s trademarks or under their own trade name.
In 2005 Elea has set-up operations in Mexico through our subsidiary, Elea México, to focus on the Women Health Care.
Our Business Development and Export Division is also supported by a highly-skilled team of professionals experienced in the areas of regulatory affairs and logistics, ensuring the most efficient and effective entry of Elea´s products into foreign markets.
To inquire about possible distribution opportunities for Elea´s products, please send us a complete description of your present pharmaceutical activities, your corporate profile and a list of those Elea´s products of interest after reviewing our Export Portfolio.
|
| NEURO-PSIQUIATRIC LINE | |
| Product | Molecule |
| OLDINOT | Donepezile |
| LAMIRAX | Lamotrigine |
| NEUROTROX | Paroxetin |
| RESTELEA | Risperidone |
| NEUTOP | Topiramate |
| CARDIOLOGY LINE | |
| Product | Molecule |
| VERATEN | Carvedilol |
| DIABEN | Rosiglitazone |
| FENSARTAN | Losartan |
| LANX | Espironolactone |
| LICUAGEN | Cilostazol |
| GENERAL LINE | |
| Product | Molecule |
| AEROXINA | Claritromycin |
| AEROXINA U.D. | Claritromycin |
| CRONOPEN | Azitromycin |
| FERLEA | Ferrous Oxide |
| LISOVYR | Aciclovyr |
| NERO | Trimetoxybenzene + Floroglucinol |
| OTC PRODUCTS |
| Pediculicides |
| Laxative Chewing Gum |
| Vaseline Soft Capsules |
| Vaseline Jelly |
| Soft Capsules (Sodium Picosulphate) |
|
| Home | Sitemap | Contact | Sitio en español |
This web site may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult with a doctor or other healthcare professional. |
© 2008. Laboratorio Elea S.A.C.I.F. y A. - All rights reserved.
|